Why the OTC Market is a Smart First Step
For many Asia-Pacific businesses, the U.S. OTC markets is the easiest way to start trading in the U.S. before moving to NASDAQ or NYSE. It’s faster, more affordable, and helps companies gain credibility with investors. In recent years, the number of businesses uplisting from OTC markets has varied—39 in 2022, 17 in 2023, and a strong rebound to 48 in 2024—showing a growing trend.
A Cost-Effective Way to Go Public
Traditional IPOs can be expensive and complicated, often requiring extensive paperwork, regulatory approvals, and significant financial investment. In contrast, OTC markets listings provide a cost-effective alternative, allowing businesses to start trading with lower upfront costs and fewer regulatory hurdles. This enables companies to access capital markets, attract investors, and establish a solid financial track record before making the move to a major exchange. By gradually increasing market visibility and investor confidence, businesses can position themselves for a smoother and more successful uplisting process while minimizing financial risk.
Addressing Liquidity Concerns
The OTC markets typically experiences lower trading volumes compared to major exchanges, which can present liquidity challenges for businesses. However, companies can mitigate these risks by maintaining strong financial transparency, implementing proactive investor relations strategies, and gradually increasing market engagement. By consistently demonstrating growth potential and fostering investor confidence, businesses can enhance liquidity over time. Many companies have successfully navigated this pathway, leveraging the OTC markets as a stepping stone to secure funding, attract institutional investors, and ultimately uplist to a major exchange.
How Hexcellence Consulting Can Help
At Hexcellence Consulting, we specialize in helping companies list on the OTC Markets, Nasdaq, and NYSE. As a leading corporate advisory firm in Malaysia, we provide expert support for companies navigating the IPO process and U.S. market entry. In fact, we’re the first OTC Markets Premium Provider in the Asia-Pacific region.
Let us help you empower your business today! For more information about our advisory and consultation services and fees, contact us here or at +60 11 5636 6286 for our assistance.
